Vanguard PRIMECAP Core Fund BSX Holdings History
Vanguard PRIMECAP Core Fund's Boston Scientific Corp Holding Summary
As of 2025-03-31, VANGUARD FENWAY FUNDS held 3.03 Mil shares of Boston Scientific Corp(BSX), totaling $305.77 Mil. This investment constitutes 2.69% of their stock portfolio, and VANGUARD FENWAY FUNDS now holds 0.2% of the outstanding Boston Scientific Corp(BSX) stock.
The initial trade took place in 2019Q3. And since then Vanguard PRIMECAP Core Fund has made 6 purchases of BSX, at an average price of $42.56, for a total of 3.83 Mil shares. In addition, there have been 13 sales at an average price of $49.21 for 802,050.00 shares. Based on historical transaction data and BSX's current price of $104.65, Vanguard PRIMECAP Core Fund's estimated gain on his BSX holdings is $193.54 Mil, reflecting a 118.64% gain to date.
Vanguard PRIMECAP Core Fund BSX ($104.65) Holding Chart
Vanguard PRIMECAP Core Fund BSX ($104.65) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
